OpenAlex
PricingAboutJobs
Log inGet started
Work

Canakinumab for the treatment of acute flares in difficult‐to‐treat gouty arthritis: Results of a multicenter, phase II, dose‐ranging study

HTML

Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.27600
Authors: Alexander So, Marc De Meulemeester, Andrey Pikhlak, A. Eftal Yücel, Dominik Richard, Valda Murphy, Udayasankar Arulmani, Peter Sallstig, Naomi Schlesinger
Institutions: Centre Hospitalier Universitaire Vaudois, Russian University of Medicine, Başkent University, Novartis (Switzerland), University of Medicine and Dentistry of New Jersey
Language: English

Topic: Gout, Hyperuricemia, Uric Acid
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: canakinumab, acute gouty arthritis, IL-1β, refractory gout, triamcinolone acetonide, dose-response relationship, analgesia, adverse events, tolerability
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2084187644
FWCI: 33.58
Cites: 32
Cited by: 315
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms